Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Voyageur Signs Letter of Intent with Large Multinational Pharmaceutical Company (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

SQI Diagnostics Inc V.SQD.H

Technology Scientific & Technical Instruments
SQI Diagnostics Inc. is a Canada-based company that is focused on lung health. The Company is engaged in the development and manufacturing of respiratory health and precision medicine tests that run on its fully automated systems. Its clinical solutions include Rapid Acute Lung Injury Diagnostic (RALI-Dx), lung transplant diagnostics, COVID-19 testing and surveillance testing solutions. Its RALI-Dx IL-6 Severity Triage Test and the RALI-fast IL-6 Severity Triage point of care (POC) Test each help clinicians identify which patients with SARS-CoV-2 are predicted to have a severe inflammatory response and should or should not be admitted to the hospital. Its RALI-Dx delivers results from the lab in less than an hour while RALI-fast delivers results at the patient point-of-care in about 15 minutes. The Company’s TORdx LUNG Test measures inflammation at the molecular level to assess the health of the donor lung. The Company is also focused on its organ transplant pipeline of products.


TSXV:SQD.H - Post by User

SQI Diagnostics Inc > High Profile Involvement.... time to shine SQI.
<< Previous
 Bullboard Posts
Next >>
User Avatar Image
(157)
•••
Comment by cleareyeon Jul 24, 2021 1:16am
143 Views
Post# 33600406

RE:RE:RE:RE:High Profile Involvement.... time to shine SQI.

RE:RE:RE:RE:High Profile Involvement.... time to shine SQI. I belive you're right ResearchGuy,

The EUA application is still ongoing for the Home Antibody test. I think that it must be valid and moving forward if Azova signed the agreement that was announced 8 days ago.

I highlighted the announcement this afternoon to make sure it was thrashed out this weekend so investors who reference this board can inform themselves before Monday morning.

For some, Monday may be a buying opportunity. For me, I have the shares I want of SQD, but, I will be holding.

I just hope that shareholders inform themselves before being tempted to sell. I think that this company represents an unique opportunity with high potential of financial rewards. However, this news release is a disappointment.

cleareye.


<< Previous
 Bullboard Posts
Next >>
Dealroom for high-potential pre-IPO opportunities